Immunogenicity in pig-tailed macaques of poliovirus replicons expressing HIV-1 and SIV antigens and protection against SHIV-89.6P disease

Virology

Volumn 315, Issue 2, 2003, Pages 425-437

  Fultz, Patricia N ^a   Stallworth, Jackie ^a   Porter, Donna ^a   Novak, Miroslav ^a   Anderson, Marie J ^a   Morrow, Casey D ^a  

^a UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

Author keywords

Immunization; Poliovirus replicon; SHIV; Vaccine

Indexed keywords

ANTIBODY; CD4 ANTIGEN; ENVELOPE PROTEIN; GAG PROTEIN; GAMMA INTERFERON; HUMAN IMMUNODEFICIENCY VIRUS 1 ANTIGEN; INTERLEUKIN 12; SIMIAN IMMUNODEFICIENCY VIRUS ANTIGEN; UNCLASSIFIED DRUG; VIRUS ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ANTIGEN EXPRESSION; ARTICLE; CAUSE OF DEATH; CELLULAR IMMUNITY; CONTROLLED STUDY; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMORAL IMMUNITY; IMMUNIZATION; IMMUNOGENICITY; MACACA; MONKEY DISEASE; MONONUCLEAR CELL; NONHUMAN; POLIOMYELITIS VIRUS; PRIORITY JOURNAL; PROVOCATION TEST; REPLICON; SIMIAN IMMUNODEFICIENCY VIRUS; T LYMPHOCYTE; VIREMIA; VIRUS ISOLATION;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MACACA; MACACA NEMESTRINA; POLIOVIRUS; SIMIAN IMMUNODEFICIENCY VIRUS; SIMIAN-HUMAN IMMUNODEFICIENCY VIRUS; SUS SCROFA;

EID: 0142154176     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0042-6822(03)00546-4     Document Type: Article

References (72)

1. Amara R.R., Villinger F., Altman J.D., Lydy S.L., O'Neil S.P., Staprans S.I., Montefiori D.C., Xu Y., Herndon J.G., Wyatt L.S., Candido M.A., Kozyr N.L., Earl P.L., Smith J.M., Ma H.-L., Grimm B.D., Hulsey M.L., Miller J., McClure H.M., McNicholl J.M., Moss B., Robinson H.L. Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine. Science. 292:2001;69-74.
2. Andersson S., Makitalo B., Thorstensson R., Franchini G., Tartaglia J., Limbach K., Paoletti E., Putkonen P., Biberfeld G. Immunogenicity and protective efficacy of a human immunodeficiency virus type 2 recombinant canarypox (ALVAC) vaccine candidate in cynomolgus monkeys. J. Infect. Dis. 174:1996;977-985.
3. Ansardi D.C., Porter D.C., Morrow C.D. Complementation of a poliovirus defective genome by a recombinant vaccinia virus which provides P1 capsid protein in trans. J. Virol. 67:1993;3684-3690.
4. Baba T.W., Liska V., Hofmann-Lehmann R., Vlasak J., Xu W., Ayehunie S., Cavacini L.A., Posner M.R., Katinger H., Stiegler G., Bernacky B.J., Rizvi T.A., Schmidt R., Hill L.R., Keeling M.E., Lu Y., Wright J.E., Chou T.-C., Ruprecht R.M. Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection. Nat. Med. 6:2000;200-206.
5. Barouch D.H., Santra S., Schmitz J.E., Kuroda M.J., Fu T.-M., Wagner W., Bilska M., Craiu A., Zheng X.X., Krivulka G.R., Beaudry K., Lifton M.A., Nickerson C.E., Trigona W.L., Punt K., Freed D.C., Guan L., Dubey S., Casimiro D., Simon A., Davies M.-E., Chastain M., Strom T.B., Gelman R.S., Montefiori D.C., Lewis M.G., Emini E.A., Shiver J.W., Letvin N.L. Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination. Science. 290:2000;486-492.
6. Belyakov I.M., Hel Z., Kelsall B., Kuznetsov V.A., Ahlers J.D., Nacsa J., Watkins D.I., Allen T.M., Sette A., Altman J., Woodward R., Markham P.D., Clements J.D., Franchini G., Strober W., Berzofsky J.A. Mucosal AIDS vaccine reduces disease and viral load in gut reservoir and blood after mucosal infection of macaques. Nat. Med. 7:2001;1320-1326.
7. Berglund P., Quesada-Rolander M., Putkonen P., Biberfeld G., Thorstensson R., Liljestrom P. Outcome of immunization of cynomolgus monkeys with recombinant Semliki Forest virus encoding human immunodeficiency virus type 1 envelope protein and challenge with a high dose of SHIV-4 virus. AIDS Res. Hum. Retroviruses. 13:1997;1487-1495.
8. Buge S.L., Richardson E., Alipanah S., Markham P., Cheng S., Kalyan N., Miller C.J., Lubeck M., Udem S., Eldridge J., Robert-Guroff M. An adenovirus-simian immunodeficiency virus env vaccine elicits humoral, cellular, and mucosal immune responses in rhesus macaques and decreases viral burden following vaginal challenge. J. Virol. 71:1997;8531-8541.
9. Chen X., Scala G., Quinto I., Liu W., Chun T.-W., Justement J.S., Cohen O.J., vanCott T.C., Iwanicki M., Lewis M.G., Greenhouse J., Barry T., Venzon D., Fauci A.S. Protection of rhesus macaques against disease progression from pathogenic SHIV-89.6PD by vaccination with phage-displayed HIV-1 epitopes. Nat. Med. 7:2001;1225-1231.
10. + T-cell-depleted rhesus macaques. J. Virol. 75:2001;1547-1550.
11. Cho M.W., Kim Y.B., Lee M.K., Gupta K.C., Ross W., Plishka R., Buckler-White A., Igarashi T., Theodore T., Byrum R., Kemp C., Montefiori D.C., Martin M.A. Polyvalent envelope glycoprotein vaccine elicits a broader neutralizing antibody response but is unable to provide sterilizing protection against heterologous simian/human immunodeficiency virus infection in pigtailed macaques. J. Virol. 75:2001;2224-2234.
12. Crotty S., Lohman B.L., Lu F.X.-S., Tang S., Miller C.J., Andino R. Mucosal immunization of cynomolgus macaques with two serotypes of live poliovirus vectors expressing simian immunodeficiency virus antigens stimulation of humoral, mucosal, and cellular immunity . J. Virol. 73:1999;9485-9495.
13. Crotty S., Miller C.J., Lohman B.L., Neagu M.R., Compton L., Lu D., Lu F.X.-S., Fritts L., Lifson J.D., Andino R. Protection against simian immunodeficiency virus vaginal challenge by using Sabin poliovirus vectors. J. Virol. 75:2001;7435-7452.
14. Daniel M.D., Kirchhoff F., Czajak S.C., Sehgal P.K., Desrosiers R.C. Protective effects of a live attenuated SIV Vaccine with a deletion in the nef gene. Science. 258:1992;1938-1941.
15. Davis N.L., Caley I.J., Brown K.W., Betts M.R., Irlbeck D.M., McGrath K.M., Connell M.J., Montefiori D.C., Frelinger J.A., Swanstrom R., Johnson P.R., Johnston R.E. Vaccination of macaques against pathogenic simian immunodeficiency virus with Venezuelan equine encephalitis virus replicon particles. J. Virol. 74:2000;371-378.
16. Egan M.A., Charini W.A., Kuroda M.J., Schmitz J.E., Racz P., Tenner-Racz K., Manson K., Wyand M., Lifton M.A., Nickerson C.E., Fu T., Shiver J.W., Letvin N.L. Simian immunodeficiency virus (SIV) gag DNA-vaccinated rhesus monkeys develop secondary cytotoxic T-lymphocyte responses and control viral replication after pathogenic SIV infection. J. Virol. 74:2000;7485-7495.
17. Fultz P.N., Gluckman J.-C., Muchmore E., Girard M. Transient increases in numbers of infectious cells in an HIV-infected chimpanzee following immune stimulation. AIDS Res. Hum. Retroviruses. 8:1992;313-317.
18. Gao F., Morrison S.G., Robertson D.L., Thornton C.L., Craig S., Karlsson G., Sodroski J., Morgado M., Galvao-Castro B., von Briesen H., Beddows S., Weber J., Sharp P., Shaw G.M., Hahn B.H. Molecular cloning and analysis of functional envelope genes from human immunodeficiency virus type 1 sequence subtypes A through G. J. Virol. 70:1996;1651-1667.
19. Gao F., Yue L., Craig S., Thornton C.L., Robertson D.L., McCutchan F.E., Bradac J.A., Sharp P.M., Hahn B.H. Genetic variation of HIV type 1 in four World Health Organization-sponsored vaccine evaluation sites generation of functional envelope (glycoprotein 160) clones representative of sequence subtypes A, B, C, and E . AIDS Res. Hum. Retroviruses. 10:1994;1359-1368.
20. Gaschen B., Taylor J., Yusim K., Foley B., Gao F., Lang D., Novitsky V., Haynes B., Hahn B.H., Bhattacharya T., Korber B. Diversity considerations in HIV-1 vaccine selection. Science. 296:2002;2354-2360.
21. Gorelick R.J., Benveniste R.E., Lifson J.D., Yovandich J.L., Morton W.R., Kuller L., Flynn B.M., Fisher B.A., Rossio J.L., Piatak M. Jr., Bess J.W. Jr., Henderson L.E., Arthur L.O. Protection of Macaca nemestrina from disease following pathogenic simian immunodeficiency virus (SIV) challenge utilization of SIV nucleocapsid mutant DNA vaccines with and without an SIV protein boost . J. Virol. 74:2000;11935-11949.
22. + T cell responses by a DNA-SIV and NYVAC-SIV prime/boost regimen. J. Immunol. 167:2001;7180-7191.
23. Hu S.-L., Abrams K., Barber G.N., Moran P., Zarling J.M., Langlois A.J., Kuller L., Morton W.R., Benveniste R.E. Protection of macaques against SIV infection by subunit vaccines of SIV envelope glycoprotein gp160. Science. 255:1992;456-459.
24. gag and cholera toxin adjuvant induces Th1/Th2 help for virus-specific immune responses in reproductive tissues. J. Immunol. 161:1998;5952-5958.
25. Israel Z.R., Edmonson P.F., Maul D.H., O'Neil S.P., Mossman S.P., Thiriart C., Fabry L., Van Opstal O., Bruck C., Bex F., Burny A., Fultz P.N., Mullins J.I., Hoover E.A. Incomplete protection, but suppression of virus burden, elicited by subunit simian immunodeficiency virus vaccines. J. Virol. 68:1994;1843-1853.
26. Jackson C.A., Cobbs C., Peduzzi J.D., Novak M., Morrow C.D. Repetitive intrathecal injections of poliovirus replicons result in gene expression in neurons of the central nervous system without pathogenesis. Hum. Gene Ther. 12:2001;1827-1841.
27. + T cells, and AIDS . J. Virol. 71:1997;4016-4023.
28. Joag S.V., Li Z., Wang C., Foresman L., Jia F., Stephens E.B., Zhuge W., Narayan O. Passively administered neutralizing serum that protected macaques against infection with parenterally inoculated pathogenic simian-human immunodeficiency virus failed to protect against mucosally inoculated virus. AIDS Res. Hum. Retroviruses. 15:1999;391-394.
29. Johnson R.P., Lifson J.D., Czajak S.C., Cole K.S., Manson K.H., Glickman R., Yang J., Montefiori D.C., Montelaro R., Wyand M.S., Desrosiers R.C. Highly attenuated vaccine strains of simian immunodeficiency virus protect against vaginal challenge inverse relationship of degree of protection with level of attenuation . J. Virol. 73:1999;4952-4961.
30. + lymphocyte depletion in rhesus monkeys. J. Virol. 71:1997;4218-4225.
31. 89.6P). Virology. 279:2001;241-256.
32. Kumar A., Lifson J.D., Silverstein P.S., Jia F., Sheffer D., Li Z., Narayan O. Evaluation of immune responses induced by HIV-1 gp120 in rhesus macaques effect of vaccination on challenge with pathogenic strains of homologous and heterologous simian human immunodeficiency viruses . Virology. 274:2000;149-164.
33. Kumar A., Narayan O. Immunization for long-term protection against AIDS using the macaque model. Virology. 285:2001;1-5.
34. Letvin N.L. Strategies for an HIV vaccine. J. Clin. Invest. 110:2002;15-20.
35. Letvin N.L., Montefiori D.C., Yasutomi Y., Perry H.C., Davies M.-E., Lekutis C., Alroy M., Freed D.C., Lord C.I., Handt L.K., Liu M.A., Shiver J.W. Potent, protective anti-HIV immune responses generated by bimodal HIV envelope DNA plus protein vaccination. Proc. Natl. Acad. Sci. USA. 94:1997;9378-9383.
36. Ljungberg K., Rollman E., Eriksson L., Hinkula J., Wahren B. Enhanced immune response after DNA vaccination with combined envelope genes from different HIV-1 subtypes. Virology. 302:2002;44-57.
37. Lu S., Arthos J., Montefiori D.C., Yasutomi Y., Manson K., Mustafa F., Johnson E., Santoro J.C., Wissink J., Mullins J.I., Haynes J.R., Letvin N.L., Wyand M., Robinson H.L. Simian immunodeficiency virus DNA vaccine trial in macaques. J. Virol. 70:1996;3978-3991.
38. Lubeck M.D., Natuk R.J., Chengalvala M., Chanda P.K., Murthy K.K., Murthy S., Mizutani S., Lee S.-G., Wade M.S., Bhat B.M., Bhat R., Dheer S.K., Eichberg J.W., Davis A.R., Hung P.P. Immunogenicity of recombinant adenovirus-human immunodeficiency virus vaccines in chimpanzees following intranasal administration. AIDS Res. Hum. Retroviruses. 10:1994;1443-1449.
39. Mandl S., Hix L., Andino R. Preexisting immunity to poliovirus does not impair the efficacy of recombinant poliovirus vaccine vectors. J. Virol. 75:2001;622-627.
40. Marthas M.L., Sutjipto S., Higgins J., Lohman B., Torten J., Luciw P.A., Marx P.A., Pedersen N.C. Immunization with a live, attenuated simian immunodeficiency virus (SIV) prevents early disease but not infection in rhesus macaques challenged with pathogenic SIV. J. Virol. 64:1990;3694-3700.
41. Mascola J.R., Lewis M.G., Stiegler G., Harris D., VanCott T.C., Hayes D., Louder M.K., Brown C.R., Sapan C.V., Frankel S.S., Lu Y., Robb M.L., Katinger H., Birx D.L. Protection of macaques against pathogenic simian/human immunodeficiency virus 89.6PD by passive transfer of neutralizing antibodies. J. Virol. 73:1999;4009-4018.
42. Mascola J.R., Stiegler G., vanCott T.C., Katinger H., Carpenter C.B., Hanson C.E., Beary H., Hayes D., Frankel S.S., Birx D.L., Lewis M.G. Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies. Nat. Med. 6:2000;207-210.
43. Matano T., Shibata R., Siemon C., Connors M., Lane H.C., Martin M.A. Administration of an anti-CD8 monoclonal antibody interferes with the clearance of chimeric simian/human immunodeficiency virus during primary infections of rhesus macaques. J. Virol. 72:1998;164-169.
44. McCormick-Davis C., Zhao L.-J., Mukherjee S., Leung K., Sheffer D., Joag S.V., Narayan O., Stephens E.B. Chronology of genetic changes in the vpu, env, and nef genes of chimeric simian-human immunodeficiency virus (strain HXB2) during acquisition of virulence for pig-tailed macaques. Virology. 248:1998;275-283.
45. + T cell depletion on virus replication in rhesus macaques immunized with a live, attenuated simian immunodeficiency virus vaccine. J. Exp. Med. 191:2000;1921-1931.
46. Modlin J.F. Poliomyelitis and poliovirus immunizations. Rotbart H.A. Human Enterovirus Infections. 1995;195-220 American Society for Microbiology, Washington, DC.
47. Montefiori D.C., Baba T.W., Li A., Bilska M., Ruprecht R.M. Neutralizing and infection-enhancing antibody responses do not correlate with the differential pathogenicity of SIVmac239delta3 in adult and infant rhesus monkeys. J. Immunol. 157:1996;5528-5535.
48. Mossman S.P., Bex F., Berglund P., Arthos J., O'Neil S.P., Riley D., Maul D.H., Bruck C., Momin P., Burny A., Fultz P.N., Mullins J.I., Liljestrom P., Hoover E.A. Protection against lethal simian immunodeficiency virus SIVsmmPBj14 disease by a recombinant Semliki Forest virus gp160 vaccine and by a gp120 subunit vaccine. J. Virol. 70:1996;1953-1960.
49. Murphy C.G., Lucas W.T., Means R.E., Czajak S., Hale C.L., Lifson J.D., Kaur A., Johnson R.P., Knipe D.M., Desrosiers R.C. Vaccine protection against simian immunodeficiency virus by recombinant strains of herpes simplex virus. J. Virol. 74:2000;7745-7754.
50. Nathanson N., Mathieson B.J. Biological considerations in the development of a human immunodeficiency virus vaccine. J. Infect. Dis. 182:2000;579-589.
51. Novak M.J., Smythies L.E., McPherson S.A., Smith P.D., Morrow C.D. Poliovirus replicons encoding the B subunit of Helicobacter pylori urease elicit a Th1 associated immune response. Vaccine. 17:1999;2384-2391.
52. Ourmanov I., Brown C.R., Moss B., Carroll M., Wyatt L., Pletneva L., Goldstein S., Venzon D., Hirsch V.M. Comparative efficacy of recombinant modified vaccinia virus Ankara expressing simian immunodeficiency virus (SIV) Gag-Pol and/or Env in macaques challenged with pathogenic SIV. J. Virol. 74:2000;2740-2751.
53. Parren P.W.H.I., Marx P.A., Hessell A.J., Luckay A., Harouse J., Cheng-Mayer C., Moore J.P., Burton D.R. Antibody protects macaques against vaginal challenge with a pathogenic R5 simian/human immunodeficiency virus at serum levels giving complete neutralization in vitro. J. Virol. 75:2001;8340-8347.
54. Polacino P., Stallard V., Klaniecki J.E., Montefiori D.C., Langlois A.J., Richardson B.A., Overbaugh J., Morton W.R., Benveniste R.E., Hu S.-L. Limited breadth of the protective immunity elicited by simian immunodeficiency virus SIVmne gp160 vaccines in a combination immunization regimen. J. Virol. 73:1999;618-630.
55. Porter D.C., Ansardi D.C., Choi W.S., Morrow C.D. Encapsidation of genetically engineered poliovirus mini-replicons which express HIV-1 gag and pol proteins upon infection. J. Virol. 67:1993;3712-3719.
56. Porter D.C., Wang J., Moldoveanu Z., McPherson S., Morrow C.D. Immunization of mice with poliovirus replicons expressing the C-fragment of tetanus toxin protects against lethal challenge with tetanus toxin. Vaccine. 15:1997;257-264.
57. 89.6p express virus in semen during primary infection new model for genital tract shedding and transmission . J. Infect. Dis. 183:2001;1023-1030.
58. Putkonen P., Quesada-Rolander M., Leandersson A.-C., Schwartz S., Thorstensson R., Okuda K., Wahren B., Hinkula J. Immune responses but no protection against SHIV by gene-gun delivery of HIV-1 DNA followed by recombinant subunit protein boosts. Virology. 250:1998;293-301.
59. Ren R., Racaniello V.R. Poliovirus spreads from muscle to the central nervous system by neural pathways. J. Infect. Dis. 166:1992;747-752.
60. Robinson H.L., Montefiori D.C., Johnson R.P., Manson K.H., Kalish M.L., Lifson J.D., Rizvi T.A., Lu S., Hu S.-L., Mazzara G.P., Panicali D.L., Herndon J.G., Glickman R., Candido M.A., Lydy S.L., Wyand M.S., McClure H.M. Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations. Nat. Med. 5:1999;526-534.
61. Romano L., Venturi G., Catucci M., De Milito A., Valensin P.E., Zazzi M. Evaluation of cell-free and cell-associated peripheral blood human immunodeficiency virus type 1 RNA response to antiretroviral therapy. J. Infect. Dis. 179:1999;361-366.
62. Rose N.F., Marx P.A., Luckay A., Nixon D.F., Moretto W.J., Donahoe S.M., Montefiori D., Roberts A., Buonocore L., Rose J.K. An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants. Cell. 106:2001;539-549.
63. + lymphocytes. Science. 283:1999;857-860.
64. Schnell M.J., Foley H.D., Siler C.A., McGettigan J.P., Dietzschold B., Pomerantz R.J. Recombinant rabies virus as potential live-viral vaccines for HIV-1. Proc. Natl. Acad. Sci. USA. 97:2000;3544-3549.
65. Shibata R., Igarashi T., Haigwood N., Buckler-White A., Ogert R., Ross W., Willey R., Cho M.W., Martin M.A. Neutralizing antibody directed against the HIV-1 envelope glycoprotein can completely block HIV-1/SIV chimeric virus infections of macaque monkeys. Nat. Med. 5:1999;204-210.
66. Shibata R., Siemon C., Czajak S.C., Desrosiers R.C., Martin M.A. Live, attenuated simian immunodeficiency virus vaccines elicit potent resistance against challenge with a human immunodeficiency virus type 1 chimeric virus. J. Virol. 71:1997;8141-8148.
67. Shiver J.W., Fu T.-M., Chen L., Casimiro D.R., Davies M.-E., Evans R.K., Zhang Z.-Q., Simon A.J., Trigona W.L., Dubey S.A., Huang L., Harris V.A., Long R.S., Liang X., Handt L., Schleif W.A., Zhu L., Freed D.C., Persaud N.V., Guan L., Punt K.S., Tang A., Chen M., Wilson K.A., Collins K.B., Heidecker G.J., Fernandez V.R., Perry H.C., Joyce J.G., Grimm K.M., Cook J.C., Keller P.M., Kresock D.S., Mach H., Troutman R.D., Isopi L.A., Williams D.M., Xu Z., Bohannon K.E., Volkin D.B., Montefiori D.C., Miura A., Krivulka G.R., Lifton M.A., Kuroda M.J., Schmitz J.E., Letvin N.L., Caulfield M.J., Bett A.J., Youll R., Kaslow D.C., Emini E.A. Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity. Nature. 415:2002;331-335.
68. Staats H.F., Montgomery S.P., Palker T.J. Intranasal immunization is superior to vaginal, gastric, or rectal immunization for the induction of systemic and mucosal anti-HIV antibody responses. AIDS Res. Hum. Retroviruses. 13:1997;945-952.
69. Suryanarayana K., Wiltrout T.A., Vasquez G.M., Hirsch V.M., Lifson J.D. Plasma SIV RNA viral load determination by real-time quantification of product generation in reverse transcriptase-polymerase chain reaction. AIDS Res. Hum. Retroviruses. 14:1998;183-189.
70. Walker B.D., Korber B.T. Immune control of HIV the obstacles of HLA and viral diversity . Nat. Immunol. 2:2001;473-475.
71. Wang S.-W., Kozlowski P.A., Schmelz G., Manson K., Wyand M.S., Glickman R., Montefiori D., Lifson J.D., Johnson R.P., Neutra M.R., Aldovini A. Effective induction of simian immunodeficiency virus-specific systemic and mucosal immune responses in primates by vaccination with proviral DNA producing intact but noninfectious virions. J. Virol. 74:2000;10514-10522.
72. Wyand M.S., Manson K.H., Garcia-Moll M., Montefiori D., Desrosiers R.C. Vaccine protection by a triple deletion mutant of simian immunodeficiency virus. J. Virol. 70:1996;3724-3733.